Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan for Hospitalized COVID-19 Patients
NCT04328012Phase 3Terminated
- Sponsor
- Bassett Healthcare Network
- Start
- Apr 2020
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of losartan in coronavirus disease 2019 (COVID-19), sponsored by Bassett Healthcare Network. Started Apr 2020; status: terminated.
02
Drugs
losartan
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04328012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04328012.